NCAPG As a Novel Prognostic Biomarker in Glioma

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Mar 14

PMID 35280743

Authors

Xiulin Jiang

Yulin Shi

Xi Chen

Haitao Xu

Bohu Liu

Fan Zhou

Xiaobin Huang

William C Cho

Lihua Li

Jun Pu

Affiliations

Soon will be listed here.

Abstract

Background: Non-SMC condensin I complex subunit G (NCAPG) is expressed in various human cancers, including gliomas. However, its biological function in glioma remains unclear. The present study was designed to determine the biological functions of NCAPG in glioma and to evaluate the association of NCAPG expression with glioma progression.

Methods: Clinical data on patients with glioma were obtained from The Cancer Genome Atlas (TCGA), the Chinese Glioma Genome Atlas (CGGA), the Gene Expression Omnibus (GEO), and the Rembrandt and Gravendeel databases. The correlations among NCAPG expression, pathological characteristics, and clinical outcome were evaluated. In addition, the correlations of NCAPG expression with immune cell infiltration and glioma progression were analyzed.

Results: NCAPG expression was higher in gliomas than in adjacent normal tissues. Higher expression of NCAPG in gliomas correlated with poorer prognosis, unfavorable histological features, absence of mutations in the isocitrate dehydrogenase gene (), absence of chromosome 1p and 19q deletions, and responses to chemoradiotherapy. Univariate and multivariate Cox analysis demonstrated, in addition to patient age, tumor grade, absence of mutations, and absence of chromosome 1p and 19q deletions, NCAPG expression was independently prognostic of overall survival, disease-free survival, and progression-free survival in patients with glioma. In addition, high expression of NCAPG correlated with tumor infiltration of B cells, CD4+ T cells, CD8+ T cells, neutrophils, macrophages, and dendritic cells. Gene set enrichment analysis (GSEA) indicated that high NCAPG expression was associated with cell proliferation and immune response-related signaling pathways. NCAPG knockdown in glioma cell lines significantly reduced cell survival, proliferation, and migration.

Conclusion: NCAPG expression correlates with glioma progression and immune cell infiltration, suggesting that NCAPG expression may be a useful prognostic biomarker for glioma.

Citing Articles

SOCS1: A potential diagnostic and prognostic marker for aggressive gliomas and a new target for immunotherapy.

Gu C, Chen X, Wu J, Zhang Y, Zhong L, Luo H Medicine (Baltimore). 2024; 103(49):e40632.

PMID: 39654174 PMC: 11630960. DOI: 10.1097/MD.0000000000040632.

Novel candidate metastasis-associated genes for synovial sarcoma.

Zhao Z, Niu J, Wang J, Zhang R, Liang H, Ma Y J Cell Mol Med. 2024; 28(14):e18541.

PMID: 39046429 PMC: 11267982. DOI: 10.1111/jcmm.18541.

MRPS23 is a novel prognostic biomarker and promotes glioma progression.

Wang Q, Chen G, Liu L, Peng X, Yang X, Yang L Aging (Albany NY). 2024; 16(3):2457-2474.

PMID: 38301044 PMC: 10911364. DOI: 10.18632/aging.205493.

is transcriptionally regulated by and activates the Wnt/β-catenin signaling pathway to promote proliferation and the cell cycle and inhibit apoptosis in colorectal cancer.

Yang H, Pu L, Li R, Zhu R J Gastrointest Oncol. 2023; 14(2):900-912.

PMID: 37201048 PMC: 10186512. DOI: 10.21037/jgo-23-63.

Identification of necroptosis-related genes as prognostic indicators for lower-grade glioma.

Huang X, Vafaei S, Li L, Wang Y, Sun J, Gao Y Am J Cancer Res. 2023; 13(2):692-708.

PMID: 36895971 PMC: 9989601.

References

Eberlein A, Takasuga A, Setoguchi K, Pfuhl R, Flisikowski K, Fries R . Dissection of genetic factors modulating fetal growth in cattle indicates a substantial role of the non-SMC condensin I complex, subunit G (NCAPG) gene. Genetics. 2009; 183(3):951-64. PMC: 2778990. DOI: 10.1534/genetics.109.106476. View

Dixit D, Prager B, Gimple R, Poh H, Wang Y, Wu Q . The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells. Cancer Discov. 2020; 11(2):480-499. PMC: 8110214. DOI: 10.1158/2159-8290.CD-20-0331. View

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

Xu P, Jiang L, Yang Y, Wu M, Liu B, Shi Y . PAQR4 promotes chemoresistance in non-small cell lung cancer through inhibiting Nrf2 protein degradation. Theranostics. 2020; 10(8):3767-3778. PMC: 7069097. DOI: 10.7150/thno.43142. View

Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

Jiang L, Ren L, Chen H, Pan J, Zhang Z, Kuang X . NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer. Cell Death Dis. 2020; 11(7):547. PMC: 7368860. DOI: 10.1038/s41419-020-02753-x. View

Zhao Z, Zhang K, Wang Q, Li G, Zeng F, Zhang Y . Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients. Genomics Proteomics Bioinformatics. 2021; 19(1):1-12. PMC: 8498921. DOI: 10.1016/j.gpb.2020.10.005. View

Huang X, Zhang F, He D, Ji X, Gao J, Liu W . Immune-Related Gene SERPINE1 Is a Novel Biomarker for Diffuse Lower-Grade Gliomas Large-Scale Analysis. Front Oncol. 2021; 11:646060. PMC: 8173178. DOI: 10.3389/fonc.2021.646060. View

Sun D, Lin C, Hung S, Kuang Y, Hseu Y, Fang C . Aberrant Expression of NCAPG is Associated with Prognosis and Progression of Gastric Cancer. Cancer Manag Res. 2020; 12:7837-7846. PMC: 7457733. DOI: 10.2147/CMAR.S248318. View

10.

Weenink B, van Brakel M, Wijers R, Sillevis Smitt P, French P, Debets R . Lack of B and T cell reactivity towards IDH1 in blood and tumor tissue from LGG patients. J Neurooncol. 2019; 144(1):79-87. PMC: 6660510. DOI: 10.1007/s11060-019-03228-6. View

11.

Claes I, Segers M, Verhoeven T, Dusselier M, Sels B, de Keersmaecker S . Lipoteichoic acid is an important microbe-associated molecular pattern of Lactobacillus rhamnosus GG. Microb Cell Fact. 2012; 11:161. PMC: 3537616. DOI: 10.1186/1475-2859-11-161. View

12.

Sun L, Hui A, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S . Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell. 2006; 9(4):287-300. DOI: 10.1016/j.ccr.2006.03.003. View

13.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

14.

Bruno T, Ebner P, Moore B, Squalls O, Waugh K, Eruslanov E . Antigen-Presenting Intratumoral B Cells Affect CD4 TIL Phenotypes in Non-Small Cell Lung Cancer Patients. Cancer Immunol Res. 2017; 5(10):898-907. PMC: 5788174. DOI: 10.1158/2326-6066.CIR-17-0075. View

15.

Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P . Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019; 4(13). PMC: 6629248. DOI: 10.1172/jci.insight.128217. View

16.

To K, Fong W, Cho W . Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies. Front Oncol. 2021; 11:635007. PMC: 8185359. DOI: 10.3389/fonc.2021.635007. View

17.

Basu A, Bodycombe N, Cheah J, Price E, Liu K, Schaefer G . An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules. Cell. 2013; 154(5):1151-1161. PMC: 3954635. DOI: 10.1016/j.cell.2013.08.003. View

18.

Jiang T, Mao Y, Ma W, Mao Q, You Y, Yang X . CGCG clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2016; 375(2):263-273. DOI: 10.1016/j.canlet.2016.01.024. View

19.

Bowman R, Wang Q, Carro A, Verhaak R, Squatrito M . GlioVis data portal for visualization and analysis of brain tumor expression datasets. Neuro Oncol. 2016; 19(1):139-141. PMC: 5193031. DOI: 10.1093/neuonc/now247. View

20.

Bassoy E, Kasahara A, Chiusolo V, Jacquemin G, Boydell E, Zamorano S . ER-mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem-like cells. EMBO J. 2017; 36(11):1493-1512. PMC: 5452011. DOI: 10.15252/embj.201695429. View